2Wang Q, Finer MH. Second-generation adenovirus veetors. Nat Med 1996; 2:714 -6.
3Kullo IJ, Mozes G, Schwartz RS, et al. Enhanced endothelium dependent relaxations after gane transfer of recombinant Endothelial nitric oxide synthase to rabbit carotidarteries. Hypertension 1997; 30(3): 314 - 20.
4Chen AF, O Brien T, Katusic ZS. Transfer and expression of recombinant nitric oxide synthase genes in the cardiovascular system. Tread Parmacol Sci 1998; 19(7): 276 -86.
5Inaba M, Toninelli E, Vanmeter G, et al. Retroviral gene transfer: Effects on endothelial cell phenotype. J Surg Res 1998; 78:31 -6.
6Nguyen TT, Nery JP. Rocha CE, et al. Mouse adenovirus (MAV-1) ex-pression in primary human endothelial cells and generationof a full-length infectious plasmid. Gene Ther 1999;6:1291 -7.
7Elizabeth G, Nabel MD. Stem cell combined with gene transfer for therapeutic Vasculogenesis 2002; 105:672 -4.
8Graea AP, Ascensao JL. hslation, characterizatian, and biologic features of bone marrow endothelial cell J Lab Clin Med 1996; 128(4): 399 -407.
9Leseche G, Ohan J, Bouttier S, et al. Above-knee femoropopliteal bypass grafting using endothelial cell seeded FIFE grafts: five-year clinical experience. Ann Vasc Surg 1995; 9:15 - 23.
